3rd Quarter - Report

BOCKORNY GROUP, INC. for ABBOTT LABORATORIES

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Provisions related to protecting Intellectual Property

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
MELISSA SCHULMAN —
PAUL SCOTT SHEARER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

HR.1908, Patent Reform Act of 2007 S.1145, Patent Reform Act of 2007

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
MELISSA SCHULMAN —
PAUL SCOTT SHEARER —
MICHAELA SIMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1908 (110th), S. 1145 (110th)

Medicare/Medicaid MMM

HR.1321, Medicare Advanced Laboratory Diagnostics Act of 2007 Issues related to payments for kidney dialysis patients S.3101, Medicare Improvements for Patients and Providers Act of 2008 HR.6331, Medicare Improvements for Patients and Providers Act of 2008 S.3118, Preserving Access to Medicare Act of 2008

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
ALEXANDER DAVID LURIE —
MELISSA SCHULMAN —
PAUL SCOTT SHEARER —
MICHAELA SIMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3118 (110th), S. 3101 (110th), H.R. 1321 (110th), H.R. 6331 (110th)

Health Issues HCR

HR.5839, to amend the Federal Food, Drug, and Cosmetics Act to improve the safety of drugs

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
MELISSA SCHULMAN —
PAUL SCOTT SHEARER —
MICHAELA SIMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5839 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.